From: Highly efficient site-specific transgenesis in cancer cell lines
GFP | IRES-EGFP | ||||
---|---|---|---|---|---|
Clone | GFP+ median | % GFP + | Clone | GFP+ median | % GFP + |
1 | 5970 | 99.2 | 1 | 461 | 98.7 |
2 | 5492 | 99.4 | 2 | 440 | 99.5 |
3 | 5655 | 98.5 | 3 | 502 | 99.3 |
4 | 5512 | 99.2 | 4 | 446 | 98.8 |
5 | 6751 | 99.6 | 5 | 538 | 99.5 |
6 | 5332 | 99.7 | 6 | 386 | 99.2 |
7 | 5990 | 99.5 | 7 | 359 | 98.7 |
8 | 5290 | 99.2 | 8 | 358 | 98.3 |
9 | 7031 | 99.6 | 9 | 371 | 98.9 |
10 | 5122 | 99.6 | 10 | 459 | 98.9 |
Average | 5814.5 | 99.35 | Average | 432.0 | 98.98 |